FDA OKs First New Drug in Years for Sickle Cell - Diverse Health

Higher Education News and Jobs

FDA OKs First New Drug in Years for Sickle Cell

Email
   
        


by Dr. Tyeese L. Gaines

The U.S. Food and Drug Administration approved a new drug on Friday that reduces the complications associated with sickle cell disease — the first drug approved for the blood disorder in more than 20 years.

The drug, called Endari, consists of L-glutamine, which is an amino acid, and is approved for sickle cell patients five years and older.

Read More

Comments

Print Friendly